Genedrive Share Discussion Threads

[thecroots] 28/3/2024 08:13

This alone ought to send any negative people packing.

'
Food and Drug Administration ("FDA") progress for the Genedrive® MT-RNR1 pharmacogenetic test (Antibiotic Induced Hearing Loss). The Company is in advanced stages of negotiating a collaboration with a USA-based Medical Group to support a highly cost-effective pathway for the necessary clinical trials.

Hazl,

I agree, its probably the only positive in there but the issue is that if it goes thru it is just for trials. Trials take at least a year or two from start to finish. Thats time GDR doesn't have unfortunately.

[hazl] 28/3/2024 08:11

Again proportionately income is 10x what it was.

· Revenue and other income of £0.24m (H1 2022/3: £0.02m)

· R&D spend of £1.9m (H1 2022/3: £2.0m)

· Operating loss of £2.4m (H1 2022/3: £2.7m)

· Cash of £1.2m as at 31 December 2023 (30 June 2023: £2.6m)

· Cash of £1.2m as at 20 March 2024 following recent receipt of R&D tax credit of £0.8m

[hazl] 28/3/2024 08:10

Many companies would be pleased with what this company has ready to go.
The commercial deals have started but have been restricted somewhat by the accreditations being necessary.



It will all become clear in the end no doubt.

We live in times where people are more risk averse that's all.

But children and stroke victims still need saving.

[bones698] 28/3/2024 08:08

So now comes the forward selling of the rights issue and this heads lower and lower until. It gets announced at 1.5p maybe. Total disaster and falling quickly now. Well done hazl

[hazl] 28/3/2024 08:07

James Cheek, CEO of genedrive plc, commented: "Following my arrival in September I have seen the organisation really move forward with our commercial enterprises and it has been encouraging to see how we have been able to generate Genedrive® MT-RNR1 kit sales both inside and outside the UK in such a short space of time. As well as our commercial focus, I have also been keen to ensure we have the right strategy for our business overall, leading to tighter controls over costs. I said in November, that for MT-RNR1, we would have a new UK site on board soon, sales coming in from overseas and a distributor in place to help us move forward with our desire to sell into the much larger USA market (subject to FDA approval). This has all been achieved and my focus going forward is on continuing with our MT-RNR1 sales, especially outside of the UK, as well as building our marketing and sales for CYP2C19 in the UK. Finally, we will seek to raise further equity funding in the coming weeks in order to provide a longer-term financing solution for the Company's exciting growth plans. On behalf of myself and the Board, I would like to thank our shareholders for their support and I look forward to what I hope will be a prosperous year."

[hazl] 28/3/2024 08:04

This alone ought to send any negative people packing.

'
Food and Drug Administration ("FDA") progress for the Genedrive® MT-RNR1 pharmacogenetic test (Antibiotic Induced Hearing Loss). The Company is in advanced stages of negotiating a collaboration with a USA-based Medical Group to support a highly cost-effective pathway for the necessary clinical trials.

'

Advanced stages!

[luckyabbeygale] 28/3/2024 08:03

Lucky I took the loss yesterday of 250 pound.

[hazl] 28/3/2024 08:03

This is a brilliant RNS showing progress.
I am sorry I was late today to read it before.

[thecroots] 28/3/2024 07:36

So they have sold units in France, Austria, Greece, saudi Arabia, Turkey, netherlands and PLUS the Brighton hospital and sales are ONLY £240k.????

Is that all?

No doubt GDR will issue share options to their sales staff again for outstanding achievement.

[terminator101] 28/3/2024 07:24

Let's have a look back to last year ...."The Board is confident that the Company will see an increase in revenues through 2023 and going forwards. The recent NICE recommendation, given the health benefits and health economics, is expected to facilitate the rollout of our AIHL product in both the UK and international markets (subject to relevant regulatory approvals)."How can you trust a single word these overpaid lifestyle directors say?

[terminator101] 28/3/2024 07:16

At the current burn rate, the Company has a cash runway through May 2024. We are confident that we will continue to gain commercial traction and securing significant revenues, but due to the time required to achieve this, as we have already stated, we will require additional funding.Tick tock it's placing is coming oclock.

[bones699] 28/3/2024 06:45

If anyone wants a really great laugh at me pls come visit my investments on AGL Angle Plc a total and utter basket case with a lying CEO called Newland leading it..£130m of cash burnt throught, no commercial contracts of any merit in sight, cash dwindling, I've been ramping that POS 💩 for over 10 f@@ing years! ☠️

And to think I've got the balls to go onto the Blackbird BB and post about a failing business, never delivering, with cash running out and an over valued market cap..Then run people's faces in it there or here, unbelievable given the 24 carot basket case and money pit that is Angle Plc. I've been ramping!

ANGLE plc
LON: AGL
OverviewFinancialsCompare
12.25 GBX -138.25 (-91.86%)all time
27 Mar, 17:07 GMT • Disclaimer

[the imperialist] 27/3/2024 21:32

That’s self-evidently not true. How’s those Cannabis stocks I sold you on the spike? 😃

[the imperialist] 27/3/2024 20:23

Every time you look in the mirror?

[letsbuy1] 27/3/2024 19:53

You wouldn’t even get close. You are not on the same level as me little boy

[letsbuy1] 27/3/2024 14:14

Albert your a bit of a. T. W. A T

[albert35911] 27/3/2024 13:29

Ticked up a minuscule that will get the suckers buying

[hazl] 26/3/2024 14:58

So any good news is ramping.
Hmmm.

[albert35911] 26/3/2024 14:05

This is doing well,let’s have a ramper give us the good news.